XBiotech Inc (XBIT) is a publicly traded Healthcare sector company. As of October 19, 2026, XBIT trades at $2.03 with a market cap of $64.63M and a P/E ratio of -1.45. XBIT moved -2.36% today. Year to date, XBIT is -11.30%; over the trailing twelve months it is -14.86%. Its 52-week range spans $2.09 to $3.62. Rallies surfaces XBIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for XBIT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.03 |
| Market Cap | $64.63M |
| P/E Ratio | -1.45 |
| EPS | $-1.49 |
| Dividend Yield | 2.10% |
| 52-Week High | $3.62 |
| 52-Week Low | $2.09 |
| Volume | 171.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-45.54M |
| Gross Margin | 0.00% |
XBIT analyst coverage data. Average price target: $0.00.